Skip to main content
Friday, October 30, 2026Oct 30

This story is free to read.

US backs waiving intellectual property rules on vaccines

In this April 28, 2021, file photo, U.S. Trade Representative Katherine Tai testifies during a Senate Appropriations subcommittee on Commerce, Justice, Science, and Related Agencies hearing on Capitol Hill in Washington. The Biden administration is throwing its support behind efforts to waive intellectual property protections for COVID-19 vaccines in an effort to speed the end of the pandemic. Tai announced the government's position in May 5 statement, amid World Trade Organization talks over easing global trade rules to enable more countries to produce more of the life-saving vaccines. (Sarah Silbiger/Pool via AP, File)
In this April 28, 2021, file photo, U.S. Trade Representative Katherine Tai testifies during a Senate Appropriations subcommittee on Commerce, Justice, Science, and Related Agencies hearing on Capitol Hill in Washington. The Biden administration is throwing its support behind efforts to waive intellectual property protections for COVID-19 vaccines in an effort to speed the end of the pandemic. Tai announced the government's position in May 5 statement, amid World Trade Organization talks over easing global trade rules to enable more countries to produce more of the life-saving vaccines. (Sarah Silbiger/Pool via AP, File) In this April 28, 2021, file photo, U.S. Trade Representative Katherine Tai testifies during a Senate Appropriations subcommittee on Commerce, Justice, Science, and Related Agencies hearing on Capitol Hill in Washington. The Biden administration is throwing its support behind efforts to waive intellectual property protections for COVID-19 vaccines in an effort to speed the end of the pandemic. Tai announced the government's position in May 5 statement, amid World Trade Organization talks over easing global trade rules to enable more countries to produce more of the life-saving vaccines. (Sarah Silbiger/Pool via AP, File)

WASHINGTON (AP) – The Biden administration on Wednesday joined calls for more sharing of the technology behind COVID-19 vaccines to help speed the end of the pandemic, a shift that puts the U.S. alongside many in the developing world who want rich countries to do more to get doses to the needy.

United States Trade Representative Katherine Tai announced the government’s position, amid World Trade Organization talks about a possible temporary waiver of its protections that would allow more manufacturers to produce the life-saving vaccines.

“The Administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines,” Tai said in a statement.

She cautioned that it would take time to reach the required global “consensus” to waive the protections under WTO rules, and U.S. officials said it would not have an immediate effect on the global supply of COVID-19 shots.

“This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,” said Tai. “The Administration’s aim is to get as many safe and effective vaccines to as many people as fast as possible.”